Camber Pharmaceuticals was honored and received the 2025 Supplier of the Year award during OptiSource’s annual vendor meeting this October. Camber has been a trusted OptiSource partner for more than a decade, supplying hundreds of generic medications across a wide range of therapeutic categories.
“Our partnership with OptiSource has never been stronger,” said Stu Messinger, Director of National Accounts. “It’s more than selling and supplying generic drugs. It’s about identifying challenges early and proactively solving supply issues together before they affect OptiSource—and ultimately, the patients we all serve.”
Camber Pharmaceuticals offers more than 250 generic products, including a growing selection of specialty and OTC medicines. With over 800 SKUs, Camber is recognized as one of the nation’s largest and fastest-growing suppliers of high-quality generic medications.
“Camber’s mission is to expand access to high-quality, affordable medicines,” said Kon Ostaficiuk, President of Camber Pharmaceuticals. “With one of the fastest-growing portfolios in the U.S. generics market, we remain focused on providing key partners like OptiSource with a reliable supply of the products they need to help keep Americans healthy.”
Looking ahead, Camber anticipates launching at least 60 new products in 2026, spanning generics, specialty generics, and OTC medicines. The company also plans to file 50+ new ANDA submissions next year, underscoring its long-term commitment to delivering reliable, cost-effective therapies across a wide range of therapeutic areas.
For more information about Camber’s product pipeline or upcoming launches, please contact your Camber representative.
